SOX9 and hepatocellular carcinoma: For instance, miR-613 is lowly expressed in colorectal cancer and has diagnostic and prognostic functions in colorectal cancer [33]; miR-613 represses hepatocellular carcinoma cell dedifferentiation through the SOX9 signaling, which provides novel therapeutic targets for hepatocellular carcinoma [34].